New app aims to simplify insulin dosing for diabetes patients
NCT ID NCT06529705
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a mobile app called EkiYou V2 that helps people with diabetes figure out how much insulin to take. 21 adults who use multiple daily insulin injections used the app for 6 weeks. The goal was to see if the app safely improves blood sugar control and makes insulin dosing easier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EkiYou V2 mobile application
What this could lead to
If successful, this app could help people with diabetes better manage their insulin doses and improve blood sugar control without needing extra medication.
What could go wrong
This is a very small, early study with only 21 participants and no comparison group. The results may not apply to everyone, and the app might not work as well in real-world, long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Montpellier
Montpellier, France, 34000, France